These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 4270680)
21. [Molecular genetic tests are not yet useful for diagnosis of malignant hyperthermia]. Ranklev-Twetman E; Isander G; Fletcher R Lakartidningen; 1992 May; 89(21):1869. PubMed ID: 1598048 [No Abstract] [Full Text] [Related]
22. [Malignant hyperthermia--postoperative changes of serum LDH and CPK isozymes (author's transl)]. Shimonaka H; Yamamoto M Masui; 1981 Feb; 30(2):141-9. PubMed ID: 7277676 [No Abstract] [Full Text] [Related]
23. A hypermetabolic reaction during anaesthesia and surgery. A case report. Hopkins D; Shipton EA S Afr J Surg; 1993 Jun; 31(2):85-8. PubMed ID: 8211415 [TBL] [Abstract][Full Text] [Related]
24. Recent advances in the understanding of anaesthetic-induced malignant hyperpyrexia. Harrison GG Anaesthesist; 1973 Aug; 22(8):373-6. PubMed ID: 4749220 [No Abstract] [Full Text] [Related]
25. [Biochemical and electromyographic studies on a family with malignant hyperpyrexia]. Konno K; Yamashiro H; Hagiwara M; Haseba J; Honda N Masui; 1974 Sep; 23(9):854-61. PubMed ID: 4475138 [No Abstract] [Full Text] [Related]
26. [Two cases of subclinical myopathy. Is it a trait for malignant hyperthermia? (author's transl)]. Sunohara N; Takagi A; Nonaka I; Satoyoshi E; Kojima S Rinsho Shinkeigaku; 1980 Jun; 20(6):448-54. PubMed ID: 7408344 [No Abstract] [Full Text] [Related]
27. [Evaluation of pre-operative creatin phosphokinase (CPK) level--usefulness as a screening test for malignant hyperpyrexia (author's transl)]. Morikawa S; Murata M; Murata H; Iwai S Masui; 1979 Feb; 28(2):187-96. PubMed ID: 423358 [No Abstract] [Full Text] [Related]
31. [Malignant hyperthermia. II. Investigation of the patient's family (author's transl)]. Plötz J Anaesthesist; 1980 Feb; 29(2):94-8. PubMed ID: 7377529 [TBL] [Abstract][Full Text] [Related]
32. Anesthesia for a patient with eosinophilic myositis. Farag HM; Naguib M; Gyasi H; Ibrahim AW Anesth Analg; 1986 Aug; 65(8):903-4. PubMed ID: 2942057 [No Abstract] [Full Text] [Related]
33. Histochemical abnormalities of muscle in malignant hyperpyrexia (MH). Schiller HH Z Neurol; 1973 Feb; 203(4):265-9. PubMed ID: 4120792 [No Abstract] [Full Text] [Related]
34. Muscle biopsy and in vitro contracture test in subjects with idiopathic HyperCKemia. Malandrini A; Orrico A; Gaudiano C; Gambelli S; Galli L; Berti G; Tegazzin V; Dotti MT; Federico A; Sorrentino V Anesthesiology; 2008 Oct; 109(4):625-8. PubMed ID: 18813041 [TBL] [Abstract][Full Text] [Related]
35. Malignant hyperthermia: screening of a family by serum-enzymes, electromyography and nerve-conduction. Kratholm S; Nielsen E Anaesth Resusc Intensive Ther; 1974; 2(4):359-63. PubMed ID: 4460754 [No Abstract] [Full Text] [Related]
36. ["Malignant hyperthermia" following NLA and spinal anaesthesia (author's transl)]. Malz H; Gullotta F; Klein H; Aebert K Anaesthesist; 1982 May; 31(5):248-51. PubMed ID: 7103033 [TBL] [Abstract][Full Text] [Related]
37. [Eulenburg's paramyotonia: clinical, histological, histochemical, ultrastructural and genetic aspects (presentation of 4 cases)]. Giacanelli M; Massi G; Tarquini D Riv Neurobiol; 1979; 25(2):178-92. PubMed ID: 554343 [No Abstract] [Full Text] [Related]
38. Editorial: Malignant hyperthermia: a pharmacogenetic disease of skeletal and cardiac muscle. Britt BA N Engl J Med; 1974 May; 290(20):1140-2. PubMed ID: 4274465 [No Abstract] [Full Text] [Related]
39. Type 2B muscle fibre deficiency in myotonia and paramyotonia congenita. A genetically determined histochemical fibre type pattern? Heene R; Gabriel RR; Manz F; Schimrigk K J Neurol Sci; 1986 Mar; 73(1):23-30. PubMed ID: 2939200 [TBL] [Abstract][Full Text] [Related]